OpportunityTitle: Biosimilar User Fee Act (BsUFA) Research Grant (U01) Clinical Trials Optional
AdditionalInformationOnEligibility: 1. Eligible Applicants  Eligible Organizations  Higher Education Institutions    Public/State Controlled Institutions of Higher Education  Private Institutions of Higher Education  The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education:    Hispanic-serving Institutions  Historically Black Colleges and Universities (HBCUs)  Tribally Controlled Colleges and Universities (TCCUs)  Alaska Native and Native Hawaiian Serving Institutions  Asian American Native American Pacific Islander Serving Institutions (AANAPISIs)  Nonprofits Other Than Institutions of Higher Education    Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)  Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)  For-Profit Organizations    Small Businesses  For-Profit Organizations (Other than Small Businesses)  Governments    State Governments  County Governments  City or Township Governments  Special District Governments  Indian/Native American Tribal Governments (Federally Recognized)  Indian/Native American Tribal Governments (Other than Federally Recognized)  U.S. Territory or Possession  Other    Independent School Districts  Public Housing Authorities/Indian Housing Authorities  Native American Tribal Organizations (other than federally recognized tribal governments)  Faith-based or Community-based Organizations  Regional Organizations  Non-domestic (non-U.S) Entities (Foreign Institutions)
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support research projects that enhance biosimilar and interchangeable biological product development and regulatory science.
GrantorContactEmailDescription: shashi.malhotra@fda.hhs.gov
GrantorContactText: Shashi Malhotra &lt;br/&gt;Grants Management Specialist &lt;br/&gt;Phone 2404027592